hylan G-F 20, Synvisc

  • Pharmacy Author:
    Omudhome Ogbru, PharmD

    Dr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University of Arizona/University Medical Center in 1996. He was a Professor of Pharmacy Practice and a Regional Clerkship Coordinator for the University of the Pacific School of Pharmacy from 1996-99.

  • Medical and Pharmacy Editor: Jay W. Marks, MD
    Jay W. Marks, MD

    Jay W. Marks, MD

    Jay W. Marks, MD, is a board-certified internist and gastroenterologist. He graduated from Yale University School of Medicine and trained in internal medicine and gastroenterology at UCLA/Cedars-Sinai Medical Center in Los Angeles.

View Osteoarthritis Overview Slideshow Pictures

GENERIC NAME: hylan G-F 20

BRAND NAME: Synvisc, Synvisc-One

GENERIC: No

PRESCRIPTION: Yes

USES: Hylan G-F 20 is used for treating pain caused by osteoarthritis of the knee.

SIDE EFFECTS: About 1 in 14 persons experience pain or swelling in the injected knee, and one third of those who do, need to have fluid removed from the knee. Side effects include:

  • injection site pain,
  • injection site stiffness,
  • injection site redness,
  • skin rash,
  • itching,
  • facial flushing and
  • facial swelling.

PREPARATIONS: Injection: 16 mg/2 ml, 48 mg/6 ml

DRUG INTERACTIONS: There are no known drug interactions with hylan G-F 20.

PREGNANCY AND BREASTFEEDING SAFETY: No adequate studies have been done in pregnant women. The risks of hylan G-F 20 during breastfeeding are not known. It is not known if hylan G-F 20 is excreted into breast milk.

STORAGE: hyland G-F 20 should be stored at room temperature, below 86 F (30 C). Any unused solution should be thrown out. It should not be frozen.

DOSING: Hylan G-F 20 is injected into the knee by a health professional. A course of treatment consists of three injections with each injection seven days apart when using Synvisc. Alternatively Synvisc-One, which contains all 3 doses (48 mg/ 6 ml) can be injected once as a single injection. Most people experience the greatest amount of relief from pain 8 to 12 weeks after beginning treatment. Some patients will require more than one course of treatment.

DRUG CLASS AND MECHANISM:

  • Hylan G-F 20 is an injectable fluid that is used to treat osteoarthritis of the knee. Osteoarthritis is a type of arthritis in which the joints of the body degenerate and become painful and stiff.
  • Osteoarthritis is the most common form of arthritis; almost 10 million Americans suffer from osteoarthritis. Most affected persons are over 45 years of age, and women are more often affected than men.
  • Joints contain a fluid, called synovial fluid, which acts as a lubricant and shock absorber. Patients with osteoarthritis have synovial fluid that is thinner than normal, and, therefore, it is less effective as a lubricant and shock-absorber.
  • Hylan G-F 20 is an elastic fluid that is made from a substance called hyaluronan, that is found in normal joint fluid.
  • Hyaluronan is the key substance in joint fluid that provides the shock-absorbing quality to the fluid, and it is essential for the proper functioning of joints.
  • When injected into the knee of a patient with osteoarthritis, hylan G-F 20 helps to restore the shock-absorbing effect of the fluid within the knee. This can reduce pain, resulting in a more active lifestyle.

Medically reviewed by Eni Williams, PharmD

Reference: FDA Prescribing Information

Medically Reviewed by a Doctor on 1/15/2016

Quick GuideOsteoarthritis (OA): Treatment, Symptoms, Diagnosis

Osteoarthritis (OA): Treatment, Symptoms, Diagnosis
FDA Logo

Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

See more info: hylan G-F 20 on RxList
RxList Logo

Need help identifying pills and medications?

Use the pill identifier tool on RxList.

Subscribe to MedicineNet's Arthritis Newsletter

By clicking Submit, I agree to the MedicineNet's Terms & Conditions & Privacy Policy and understand that I may opt out of MedicineNet's subscriptions at any time.

Health Solutions From Our Sponsors